Diffuse large B-cell lymphoma trials in Finland

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Not yet taking people in Finland
  HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before

  Where

  DO NOT EDIT

  Age

  65 years and over

  People

  276 worldwide

  Run by

  Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

  See details and how to join2025-524230-25-00 · EU 2025-524230-25-00
• Phase 2Taking people
  Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

  Where

  Helsinki, Oulu, Turku

  Age

  18 years to 70 years

  People

  213 worldwide

  Run by

  Miltenyi Biomedicine GmbH

  See details and how to joinNCT04844866 · EU 2023-506270-13-00
• Phase 3Taking people
  A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

  Where

  Helsinki, Kuopio, Oulu, Tampere, Turku

  Age

  75 years and over

  People

  300 worldwide

  Run by

  Nordic Lymphoma Group

  See details and how to joinNCT04332822 · EU 2022-502887-19-00